MedPath

Eastern Cooperative Oncology Group

Eastern Cooperative Oncology Group logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
2012-01-01
Employees
51
Market Cap
-
Website
https://ecog-acrin.org

Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation

Phase 2
Completed
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2003-01-27
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
22
Registration Number
NCT00003153
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2003-01-27
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00006004
Locations
🇵🇪

Instituto de Enfermedades Neoplasicas, Lima, Peru

🇺🇸

Mercy Medical Center, Des Moines, Iowa, United States

🇺🇸

Iowa Methodist Medical Center, Des Moines, Iowa, United States

and more 13 locations

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 3
Completed
Conditions
Kidney Cancer
First Posted Date
2003-01-27
Last Posted Date
2009-02-05
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00005966
Locations
🇵🇪

Instituto de Enfermedades Neoplasicas, Lima, Peru

🇺🇸

Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States

and more 11 locations

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 1
Completed
Conditions
Lung Cancer
First Posted Date
2003-01-27
Last Posted Date
2010-07-07
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00004225
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Phase 2
Completed
Conditions
Thymoma
Thymic Carcinoma
Interventions
First Posted Date
2003-01-27
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
46
Registration Number
NCT00010257
Locations
🇺🇸

HealthEast Cancer Care at Woodwinds Health Campus, Woodbury, Minnesota, United States

🇺🇸

Mount Nittany Medical Center, State College, Pennsylvania, United States

🇺🇸

MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States

and more 64 locations

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

Phase 3
Completed
Conditions
Leukemia
Interventions
Biological: sargramostim
Procedure: Allogeneic HCT
Drug: gemtuzumab ozogamicin (GO)
Procedure: Autologous HCT
First Posted Date
2003-01-27
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
657
Registration Number
NCT00049517
Locations
🇺🇸

Community Medical Center, Missoula, Montana, United States

🇺🇸

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

🇺🇸

Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States

and more 96 locations

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
722
Registration Number
NCT00028990
Locations
🇺🇸

CCOP - Atlanta Regional, Atlanta, Georgia, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

🇺🇸

CentraCare Health Plaza, Saint Cloud, Minnesota, United States

and more 27 locations

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
First Posted Date
2003-01-27
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00014118
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

🇺🇸

Mercy Hospital and Medical Center, Chicago, Illinois, United States

🇺🇸

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 44 locations

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Phase 2
Terminated
Conditions
Leukemia
Interventions
First Posted Date
2003-01-27
Last Posted Date
2023-07-05
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
59
Registration Number
NCT00003910
Locations
🇺🇸

Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

🇺🇸

McFarland Clinic, PC, Ames, Iowa, United States

and more 65 locations

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Phase 2
Completed
Conditions
Melanoma (Skin)
Interventions
Biological: PEG-interferon alfa-2b
First Posted Date
2003-01-27
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
32
Registration Number
NCT00049530
Locations
🇺🇸

Aultman Cancer Center at Aultman Hospital, Canton, Ohio, United States

🇺🇸

MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States

🇺🇸

UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States

and more 29 locations
© Copyright 2025. All Rights Reserved by MedPath